Recital 8, Regulation (EU) 2021/468

In forcesince 18 Mar 2021cited 4×

Given that aloe-emodin and emodin may be present in the extracts, the Authority concluded that hydroxyanthracene derivatives should be regarded as genotoxic and carcinogenic unless there are specific data to the contrary and that there is a safety concern for extracts containing hydroxyanthracene derivatives although uncertainty persists. The Authority was unable to provide advice on a daily intake of hydroxyanthracene derivatives that does not give rise to concerns for human health.

  • Judgment of the General Court (Sixth Chamber, Extended Composition) of 13 November 2024. Aloe Vera of Europe BV v European Commission.Decision

    Recital 8 of the contested regulation is worded as follows: ‘Given that aloe-emodin and emodin may be present in the extracts, [EFSA] concluded that [HADs] should be regarded as genotoxic and carcinogenic unless there are specific data …

    13 Nov 2024 · 62021TJ0189

  • Judgment of the General Court (Sixth Chamber, Extended Composition) of 13 November 2024. Ortis v European Commission.Decision

    Recital 8 of the contested regulation is worded as follows: ‘Given that aloe-emodin and emodin may be present in the extracts, [EFSA] concluded that [HADs] should be regarded as genotoxic and carcinogenic unless there are specific data …

    13 Nov 2024 · 62021TJ0271

  • Judgment of the General Court (Sixth Chamber, Extended Composition) of 13 November 2024. Aboca SpA Soc. agr. and Others v European CommissioDecision

    Recital 8 of the contested regulation is worded as follows: ‘Given that aloe-emodin and emodin may be present in the extracts, [EFSA] concluded that [HADs] should be regarded as genotoxic and carcinogenic unless there are specific data …

    13 Nov 2024 · 62021TJ0302

  • Judgment of the General Court (Sixth Chamber, Extended Composition) of 13 November 2024. Syndicat national des compléments alimentaires (SynDecision

    Recital 8 of the contested regulation is worded as follows: ‘Given that aloe-emodin and emodin may be present in the extracts, the [EFSA] concluded that [HADs] should be regarded as genotoxic and carcinogenic unless there are specific …

    13 Nov 2024 · 62021TJ0274